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Short stature, hyperkalemia, and acidosis: A defect in renal
transport of potassium. An eleven-year-old boy presented with
short stature, hyperkalemia, and metabolic acidosis. No endo-
crine cause for a short stature could be demonstrated. Renal
function, as assessed by inulin and PAH clearances, concen-
trating and diluting capacity, and ability to acidify the urine and
to excrete net acid, was normal. No defect was detected in adrenal
secretion of, or renal responsiveness to, aldosterone. A low renal
threshold for bicarbonate was documented which apparently
explained the acidosis. However, correction of the acidosis by
administration of sodium bicarbonate did not influence the
hyperkalemia, making it unlikely that an abnormality in bicar-
bonate reabsorption was the primary defect. Chlorothiazide
induced a fall in serum potassium and a rise in serum bicarbonate
to normal levels. During bicarbonate loading the rates of ex-
cretion of potassium in urine were consistently below those ob-
served in control subjects. It appeared, therefore, that the patient
had a primary abnormality in potassium excretion. The resulting
hyperkalemia caused urinary loss of bicarbonate and systemic
acidosis. Correction of both the acidosis and hyperkalemia by
chronic administration of chlorothiazide and sodium bicarbonate
has resulted in resumption of normal growth.
Retard de croissance, hyperkalléme et acidose: Un deficit du
transport renal dii potassium. Un enfant de 11 ans avait un retard
de croissance, une hyperkaliémie et une acidose métabolique.
Aucune cause endocrine du retard de croissance n'a étb trouvée.
La fonction rénale, estimée par les clearances de l'inuline et du
PAH, Ia capacité de concentration et de dilution et Ia capacité
d'acidifier l'urine, était normales. Aucun deficit de Ia secretion
d'aldostérone ou de Ia réponse rénale a l'aldostérone n'a été
mis en evidence. Un seuil renal bas des bicarbonates a été dé-
couvert, qui explique apparemment l'acidose. Cependant Ia
correction de l'acidose par l'administration de bicarbonate de
sodium n'a pas influence l'hyperkaliémie, ce qui rend peu pro-
bable que le deficit de la reabsorption de bicarbonate soit la
cause de l'ensemble. Le Chlorothiazide a determine une baisse
de Ia kaliéme et unc augmentation du bicarbonate plasmatique
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jusqu'à des valeurs normales. Pendant une charge en bicarbonate
les debits d'excretion du potassium dans les urines ont été
nettement inferieurs a ceux obtenus ehez des sujets témoins. Ii
apparait donc que le malade a une anomalie primitive de l'ex-
crétion de potassium. L'hyperkaliémie qui en est la consequence
a déterminé une perte de bicarbonate dans les urines et une
acidose systémique. La correction de l'acidose et de l'hyper-
kaliémie par l'administration permanente de Chlorothiazide et
de bicarbonate de sodium a eu pour résultat une reprise de Ia
croissance normale.
A relationship between renal tubular transport of po-
tassium and bicarbonate has been documented in both
animal and human experiments. Acute and chronic ad-
ministration of potassium chloride has been shown to cause
alkalinization of the urine, with urinary loss of bicarbonate,
and a consequent fall in the concentration of bicarbonate in
plasma. Despite this metabolic acidosis, the urine remains
alkaline. These findings are considered to account in part
for the acidosis of chronic renal insufficiency. There is only
one previous report [1], however, of a patient in whom
hyperkalemia, causative of acidosis, was not the result of
decreased glomerular filtration rate, but rather of a primary
renal defect in the transport of potassium. The present re-
port describes an 11-year-old boy who presented with short
stature and was found to have hyperkalemia and proximal
renal tubular acidosis. A defect in renal transport of potas-
sium at the level of the distal tubule was demonstrated and
was considered to be causative of the acidosis. Therapy with
chlorothiazide and sodium bicarbonate corrected the hyper-
kalemia and acidosis and resulted in "catch-up" growth.
Clinical description
M. C., an 11-year-old white boy, was admitted to the
Hospital of the Albert Einstein College of Medicine on
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November 1!, 1968, for evaluation of short stature. The
patient was the product of a 31 week uncomplicated ges-
tation. At birth his length was 47 cm and his weight 2.5 kg.
His failure to grow was first noticed by his parents at the
age of 5 years. The past history included herniorrhaphies in
1958, scarlet fever in 1965, and two fractures of the clavicle.
A heart murmer was noted at 22 months of age. There was
no history of episodes of muscular weakness.
The father is 178 cm tall and the mother 161 cm. There
are four siblings in good health and of normal height. All
have normal levels of potassium and bicarbonate in serum.
The patient was first investigated' for his failure to
thrive at the age of ten. X-rays of the skull and an intra-
venous urogram were normal. Serum potassium was found
to be 7.3 mhq/liter. The child was able to acidify (pH 5)
and to concentrate (sp. gr. 1.025) the urine. The electro-
cardiogram revealed peaked T-waves, mainly in leads I and
II. Urinary excretion of 17-ketosteroids was 2.2 mg/24 hr.
Serum growth hormone was 2 jig/ml after an overnight
fast.
Physical examination performed on admission to this
hospital revealed an alert boy. Height (122.8 cm) and weight
(23.7 kg) were both below the third percentile for age, and
would be average at age 71/2 years. The only other abnormal
finding was a grade 3/6 systolic murmur heard maximally
at the upper left sternal border, which was interpreted as
functional. Blood pressure was 110/70 mm Hg.
X-rays of the chest, skull and abdomen were normal and
epiphyseal maturation was that of a 7-year-old boy.
Initial laboratory data included blood hematocrit 36%,
hemoglobin 12 g/100 ml, WBC 8,800 per c. mm with a
normal differential count, reticulocyte count 2.8%, erytho-
cyte sedimentation rate 18 mm at one hr.
Serum chemistries were Na 142, K 7.7 and Cl 114 mhq/
liter, tCO216 mmoles/liter; Ca 9.5, P 5.2, BUN 12, creati-
nine 0.6, glucose 86 mg/100 ml; total protein 7, albumin
4 g/l00 ml; serum cholesterol 190, total bilirubin 0.4 mg/
100 ml; SOOT 68 and SOPT 16 SFU, alkaline phosphatase
16 KAU, LDH 220 U and CPK 6 BMU. Subsequent SOOT
determinations were normal.
Urinalysis revealed a pH of 5, a specific gravity of 1.025,
and no protein, glucose, or ketone bodies. The sediment
was normal. Absence of generalized renal disease was
further documented by normal inulin and PAH clearances,
urinary concentration and dilution, and urinary acidification
and excretion of titratable acid and ammonium. A titration
study revealed a renal threshold for bicarbonate of 18
mmoles/liter, which was consistent with spontaneous serum
levels usually encountered in the patient. The amount of
bicarbonate infused was calculated to raise the plasma
level at a rate of 2 mmoles/liter/hr. A solution of 0.5 M
NaHCO3 was infused at a rate of 1 ml/min, and the total
1 By Theodore Kushnick, M. D., Professor of Pediatrics, New
Jersey College of Medicine and Dentistry, who subsequently
referred him to Dr. Henneman.
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Fig. 1. Relationship between urinary excretion of bicarbonate and
the clearance of potassium during intravenous infusion of sodium
bicarbonate.
amount received by the patient at the time threshold was
reached was 160 ml, or less than 1 per cent of body weight.
This minimizes the possibility that the threshold for
bicarbonate was artificially depressed by extracellular
volume expansion.
The excretion of potassium during the bicarbonate in-
fusion test increased from 0.028 mEq/100 ml glomerular f ii-
trate, at a bicarbonate excretion rate of 0.02 mmoles/l00 ml
glomerular filtrate, to 0.1 mhq, at a bicarbonate excretion
rate of 0.24. In normal adult subjects studied under similar
conditions of volume expansion, the excretion of potassium
at comparable rates of bicarbonate excretion was con-
sistently greater, especially at low rates of bicarbonate
excretion when the difference was at least threefold. The
relationship between the clearance of potassium and the
excretion of bicarbonate is shown in Fig. 1.
Indices of thyroid function were normal: serum thyroxine
by column chromatography 3.9 jig/100 ml, T3 uptake 23
percent, and 24-hour radio-iodine uptake 32 percent.
Twenty-four hour excretion of 17-ketogenic steroids was
5 mg under control conditions, increased to 17.7 mg follow-
ing administration of metyrapone (0.5 g every 6 hr for
2 days) and to 12 mg following administration of a single
intramuscular dose of 40 U of ACTH gel. Fasting plasma
cortisol level was 8 jig/l00 ml. This value rose to 25 jig
within 4 hr after intravenous administration of 5 U of
ACTH. Twenty-four hour excretion of aldosterone was
22 jig on a regular diet, 50 pig following five days of
chlorothiazide (0.5 g twice daily) while on a diet providing
10 mEq of sodium and 40 mEq of potassium daily, and
8 jig following four days on an intake of 50 mhq of sodium
and 40 mEq of potassium per 24 hr. Fasting serum growth
hormone was less than 2 jig per ml. Following a 30 minute
intravenous infusion of arginine HC1 (0.5 g/kg body wt),
serum levels of growth hormone reached 7 jig at 30 mm,
0
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decreased to 4 jig at 60 mm, and returned to less than 2 jig
by 90 mm. These levels were considered to reflect an intact
but slightly blunted capacity to secrete growth hormone
following arginine infusion.
An ECG revealed high peaked T-waves in all precordial
leads. Repeated determinations confirmed the elevation in
serum potassium, which varied spontaneously between 7.3
and 7.7 mEq/liter, and the low tCO2 which ranged from
14 to 16 mmoles/liter. Simultaneous determinations of blood
pH ranged from 7.28 to 7.33, demonstrating a partially
compensated metabolic acidosis. On 11/19/68 the patient
was started on fludrocortisone acetate, 0.5 mg/day for four
days and 1.0 mg/day for another four days. A slight re-
duction in serum potassium to 6.1 mEq/liter and an increase
in tCO2 to 20 mmoles/liter were noted during the first half
of this period. During the last few days, however, the con-
centration of potassium rose again to 6.9. Administration of
NaHCO3, 100 mmoles/day for 24 days, corrected the aci-
dosis (tCO2 rose to 24 mmoles/liter) but failed to influence
serum potassium (average value 7 mEq/liter).
Balance studies
In February 1969, the patient was admitted to the General
Clinical Research Center; he was placed on a constant diet
Fig. 2. First metabolic study. Intake is
plotted down from the zero line, output is
plotted up from this level. Changes in
serum values are shown by the solid and
interrupted lines.
and all stools and urines were collected quantitatively.
Serum and urine electrolytes were determined on a Tech-
nicon AutoAnalyzer, employing standard techniques. The
electrolytes in the stool were determined following ashing
and resuspension in a known volume of fluid.
The details of the initial study are depicted in Fig. 2. At
the onset, the patient manifested his usual hyperkalemia
(6.7 mEq/liter) and acidemia (bicarbonate 21.4 mEq/liter).
Metyrapone produced a sodium diuresis and slight retention
of potassium. Serum K did not change significantly. Follow-
ing metyrapone, sodium excretion decreased to almost zero
while potassium excretion increased slightly. Chlorothiazide,
1 g/day, produced marked diuresis of both sodium and
potassium and a loss in weight of 850 g (4 percent of body
wt). Serum potassium decreased from 6.1 to 3.4 mEq/liter
and serum sodium from 134 to 130 mEq/liter. This coin-
cided with a cumulative negative balance for sodium of
about 200 mEq and for potassium of about 125 mEq. The
serum concentration of bicarbonate rose from 21.4 to
34.4 mEq/liter. Concomitantly net acid excretion in-
creased by approximately 50 mEq/24 hr. Administration
of NaHCO3 further lowered serum potassium and raised
serum bicarbonate. This period was followed by admini-
stration of supplemental potassium chloride, which was
retained almost quantitatively. The final 14 days of ob-
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servation, on no medication, were characterized by sodium
retention and by decrease in serum bicarbonate levels
towards initial values. A concomitant rise in serum po-
tassium reflected both a slightly positive balance of this ion,
as well as its movement from the intracellular space, due to
recurrence of acidemia.
In May 1969, the patient underwent a second balance
study (Fig. 3). The purpose of this was to test the response to
a lower dose of chlorothiazide and to examine the effects
of aldosterone and spironolactone. The diet contained
50 mEq of sodium and 45 mEq of potassium daily. Serum
and urinary electrolytes were determined as in the previous
balance study; stool analyses were not performed. d-
Aldosterone2, 0.5 and then 4 mg intramuscularly per day,
failed to elicit any change in serum or urinary potassium
and bicarbonate. Chlorothiazide, in a daily dose of 250 mg,
showed a qualitatively similar but quantitatively lesser
effect than observed in the first study. Body weight de-
creased by 500 g (2.3 percent) concomitant with a diuresis
of sodium and potassium. Serum sodium did not change;
potassium decreased from 6.3 to 3.2 mEq/liter. Serum
bicarbonate increased from 19.3 to 29.8 mEq/liter. Net
acid excretion increased by 15 mEq/day, accounting only
in part for the observed change in the buffering capacity of
the extracellular fluid. Total body potassium, determined
by external counting, was found to be 44 mFq/kg body wt
2 Obtained through the courtesy of J. Pfitzner, M. D., Ciba
Pharmaceutical Company, Summit, New Jersey.
following five days of chlorothiazide administration and
50 mEq/kg body wt under basal conditions. These values
are within normal limits [2]. The potassium content of the
red cells varied in parallel with total body potassium, being
77 mEq/liter of packed cells after treatment with chloro-
thiazide and 84 mEq/liter thereafter.
During the administration of spironolactone, a markedly
positive balance of potassium was observed, serum potas-
sium rose, sodium balance became negative, and both
sodium and bicarbonate in serum fell. Since a similar
phenomenon was observed during the administration of
metyrapone, this was interpreted as being related to al-
dosterone inhibition. Although urinary excretion of po-
tassium reached its nadir during spironolactone administra-
tion, potassium retention preceded this by two days when
large supplemental doses of potassium were given.
Following this hospitalization, the patient was maintained
on chlorothiazide, 10 mg/kg body wt per day, and sodium
bicarbonate 1.8 mmoles/kg body wt per day. With this
treatment the levels of potassium in serum varied between
3.8 and 4.9 mEq/liter, and of bicarbonate between 25 and
36 mmoles/liter. He grew 15.6 cm in 2 years and height-age
increased three years.
Discussion
M. C.'s presenting complaint was failure to grow, and
this growth retardation was attended by a similar degree of
retardation of epiphyseal maturation. The only abnormali-
Fig. 3. Second metabolic balance study. In-
take and urinary excretion of sodium are
plotted in the upper panel, corresponding
data for potassium in the lower. Serum
values are shown by the solid and inter-
rupted lines.
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ties found to account for his growth failure were hyper-
kalemia and systemic acidosis. Growth failure is known to
occur in renal insufficiency with acidosis (with or without
hyperkalemia) and in renal tubular acidosis (with normo-
or hypokalemia) [3]. In M. C., correction of the acidosis
and hyperkalemia resulted in "catch-up" growth which
supports the argument that growth failure was due to these
abnormalities.
The origins and interrelations of the acidosis and the
hyperkalemia are more difficult to define. Hyperkalemia
was a consequence neither of renal glomerular insufficiency
nor of dietary excess. It was not due to lack of cortisol or of
aldosterone production [4] or to renal unresponsiveness to
aldosterone.
It must be considered whether the defect in potassium
could be related to an abnormality in the renal handling of
sodium, since extensive clinical and experimental evidence
indicates that low rates of excretion of sodium are accom-
panied by similarly low rates of potassium excretion [5—7].
The possible mechanisms accounting for this relationship
have been thoroughly investigated during the last few years
[8—12]. As shown at the end of the first balance study, M. C.
was able to reduce his urinary sodium concentration nearly
to zero in response to salt restriction and pretreatment with
chlorothiazide. Tie was also able to increase urinary sodium
appropriately in response to administration of sodium bi-
carbonate. Concentrating and diluting capacity were nor-
mal. There were no clinical features to suggest either an
increase or a decrease in total body sodium, and his vital
signs were normal throughout. Thus no disturbance in renal
tubular transport of sodium was demonstrated.
Having dismissed as unlikely an abnormality in the ad-
renal or in the renal response to aldosterone and a defect in
sodium reabsorption, we must next consider a primary de-
fect in the tubular transport of potassium or bicarbonate or
both. A possible relationship between the renal handling of
potassium and bicarbonate was first assumed in 1932 by
Loeb et al [13], and confirmed repeatedly since that time
[14—17]. The nearly complete reabsorption of potassium in
the proximal tubule [18, 19] is not affected by even extreme
changes in systemic acid-base balance [18, 20]. Both meta-
bolic and respiratory alkalosis enhance potassium secretion
in the distal tubule [15, 21, 22] and, of more relevance to the
present study, metabolic and respiratory acidosis markedly
inhibit the distal secretion of potassium despite elevated
concentrations of potassium in plasma [23—26]. Part of this
effect can be related to changes in intratubular pH, with
potassium secretion falling as tubular fluid pH falls [27].
Of greater importance, however, is intracellular pH, a fall
in which markedly impairs potassium secretion [17, 18, 28].
According to recent evidence obtained by tracer flux studies,
this effect is the result of a decrease in the potassium trans-
port pool which is, in turn, the consequence of a diminished
potassium uptake at the peritubular level [29].
These considerations suggest the possibility that a
primary disturbance in reabsorption of bicarbonate, with
consequent metabolic acidosis, could have caused a de-
creased capacity in this patient for secretion of potassium,
with resulting hyperkalemia. That this is unlikely, however,
is evidenced by our experience with patients with primary
proximal renal tubular acidosis who have marked impair-
ment in bicarbonate reabsorption, chronic metabolic aci-
dosis, but no impairment in potassium excretion and ab-
sence of hyperkalemia [30]. Furthermore, prolonged ad-
ministration of sodium bicarbonate to M. C., a procedure
which enhances potassium secretion in normal subjects,
corrected the acidosis but not the hyperkalemia.
If a primary abnormality in reabsorption of bicarbonate
as the sole defect can be excluded, could a primary defect
in potassium excretion explain the impaired capacity to
reabsorb bicarbonate? As cited above, there is considerable
evidence that potassium loading does result in urinary loss
of bicarbonate. It has been further established that the
site of action is primarily the proximal tubule. Clapp and
Bernstein [31] observed a rise in proximal bicarbonate con-
centration during acute administration of KCI, and micro-
perfusion of peritubular capillaries at the level of the proxi-
mal tubule with solutions containing high concentrations
of K resulted in inhibition of bicarbonate reabsorption
[32]. An opposite result was described by Rector, Buttram
and Seldin [20] when rats were made hypokalemic. The
possible role that ECF volume might have played in these
changes was ruled out by Kunau et al [33]. The effects of
chronic hyperkalemia on bicarbonate excretion have not
been studied experimentally. The well-known process of
adaptation to prolonged administration of a high potassium
diet precludes development of hyperkalemia and consequent
disturbance in acid-base balance [34—36]. Nevertheless, the
peritubular micropuncture experiments of Brandis, Keyes
and Windhager [32] provide convincing evidence of the
direct effect of potassium on bicarbonate reabsorption
independent of any systemic change or variation in the
amount of filtered potassium.
It is conceivable, therefore, that the hyperkalemia in this
patient may have resulted in impaired proximal reabsorp-
tion of bicarbonate, with its loss in the urine, and resulting
acidosis. The acidosis, in turn, would then interfere further
with secretion of potassium, exaggerating the magnitude of
the abnormality. Suggestive evidence that a renal defect in
the secretion of potassium was present in this patient was
obtained from his bicarbonate titration test (Fig. 1).
Without treatment the patient was acidotic and, as a
consequence, little or no bicarbonate was delivered into the
distal part of the nephron, a condition strongly favoring
potassium retention. At higher levels of bicarbonate ex-
cretion, although the rate of potassium excretion remained
below that of the controls, the difference was minimized.
This was insufficient, however, to correct hyperkalemia,
at least over a course of three weeks' therapy with sodium
bicarbonate.
During the balance studies, both the hyperkalemia and
the acidosis were corrected by administration of the diuretic
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chiorothiazide. As potassium was lost into the urine and
normokalemic levels were achieved in response to chioro-
thiazide, bicarbonate reabsorption returned to normal, with
resulting correction of the acidosis. It is unlikely that this
effect was due to extracellular volume contraction, since the
change in body weight at this point was negligible. With
more vigorous diuretic therapy and marked sodium loss,
the patient actually became alkalotic, reflecting now both
hypokalemia and volume contraction. Under these circum-
stances his intrinsic capacity for unimpaired reabsorption
of bicarbonate was clearly demonstrated.
The lack of knowledge regarding the primary factor
responsible for the anomalies observed complicates the
characterization of the disease. It is, for instance, im-
possible to establish if the patient described here has the
same disease as the one previously studied by Arnold and
Healy [11. They both seem to have a defect in potassium
excretion. Arnold and Healy's patient was not short but
had hypertension which apparently varied directly with the
degree of hyperkalemia. M. C. consistently had normal
blood pressure. Other symptoms that were missing in M. C.
but present in the other patient were muscular weakness
and a defect in hydrogen ion excretion. However, both of
them improved markedly following the administration of
chlorothiazide. The fact that the younger patient showed less
symptomatology might suggest a time-related course of the
disease.
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